Central nervous system control of food intake

Nature

Volumn 404, Issue 6778, 2000, Pages 661-671

  Schwartz, Michael W ^a   Woods, Stephen C ^b   Porte Jr , Daniel ^a   Seeley, Randy J ^b   Baskin, Denis G ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERMEDIN; CHOLECYSTOKININ; CORTICOTROPIN RELEASING FACTOR; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYTOKINE; DEXFENFLURAMINE; DOPAMINE; GALANIN; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; GUANINE NUCLEOTIDE BINDING PROTEIN; INSULIN; INSULIN RECEPTOR; INTERLEUKIN 1BETA; LEPTIN; LEPTIN RECEPTOR; MELANOCORTIN; MELANOCORTIN RECEPTOR; NEUROPEPTIDE; NEUROPEPTIDE Y; NEUROTENSIN; NORADRENALIN; OREXIN A; OREXIN B; OXYTOCIN; PROTIRELIN; SEROTONIN; SIBUTRAMINE; UNINDEXED DRUG; UROCORTIN;

ARCUATE NUCLEUS; BODY FAT; BROWN ADIPOSE TISSUE; CALORIC INTAKE; CENTRAL NERVOUS SYSTEM; ENERGY EXPENDITURE; FOOD INTAKE; HOMEOSTASIS; HORMONAL REGULATION; HUMAN; HYPOTHALAMUS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; REVIEW; SATIETY; SEROTONINERGIC SYSTEM; SOLITARY TRACT NUCLEUS;

RODENTIA;

EID: 0034611732     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/35007534     Document Type: Review

References (121)

1. Edholm, O. G. Energy balance in man. J. Human Nutr 31, 413-131 (1977).
2. Montague, C. et al. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 387, 903-908 (1997).
3. Clement, K. et al. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 392, 330-331 (1998).
4. Vaisse, C., Clement, K., Guy-Grand, B. & Froguel, P. A frameshift mutation in human MC4R is associated with a dominant form of obesity. Nature Genet. 20, 113-114 (1998).
5. Yeo, G. et al. A frameshift mutation in MC4R associated with dominantly inherited human obesity. Nature Genet. 20, 111-112 (1998).
6. Harris, R. B. S., Kasser, T. R. & Martin, R. J. Dynamics of recovery of body composition after overfeeding, food restriction or starvation of mature female rats. J. Nutr. 116, 2536-2546 (1986).
7. Kennedy, G. C. The role of depot fat in the hypothalamic control of food intake in the rat. Proc. R. Soc. Lond. B 140, 579-592 (1953).
8. Gibbs, J., Young, R. C. & Smith, G. P. Cholecystokinin decreases food intake in rats. J. Comp. Physiol. Psychol. 84, 488-495 (1973).
9. Baura, G. et al. Saturable transport of insulin from plasma into the central nervous system of dogs in vivo: a mechanism for regulated insulin delivery to the brain. J. Clin. Invest. 92, 1824-1830 (1993).
10. Woods, S., Lotter, E., McKay, L. & Porte, D. J. Chronic intracerebroventricular infusion of insulin reduces food intake and body weight of baboons. Nature 282, 503-505 (1979).
11. Zhang, Y. et al. Positional cloning of the mouse obese gene and its human homologue. Nature 372, 425-432 (1994).
12. Bagdade, J. D., Bierman, E. L. & Porte, D. Jr The significance of basal insulin levels in the evaluation of the insulin response to glucose in diabetic and nondiabetic subjects. J. Clin. Invest. 46, 1549-1557 (1967).
13. Considine, R. V. et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. New Eng. J. Med. 334, 292-295 (1996).
14. Schwartz, M. W. et al. Cerebrospinal fluid leptin levels: relationship to plasma levels and to adiposity in humans. Nature Med. 2, 589-593 (1996).
15. Baskin, D. G., Wilcox, B. J., Figlewicz, D. P. & Dorsa, D. M. Insulin and insulin-like growth factors in the CNS. Trends Neurosci. 11, 107-111 (1988).
16. Baskin, D. Breininger, J. & Schwartz, M. Leptin receptor mRNA identifies a subpopulation of neuropeptide Y neurons activated by fasting in rat hypothalamus. Diabetes 48, 828-833 (1999).
17. Cheung, C., Clifton, D. & Steiner, R. Proopimelanocortin neurons are direct targets for leptin in the hypothalamus. Endocrinology 138, 4489-4492 (1997).
18. Weigle, D. S. et al. Recombinant ob protein reduces feeding and body weight in the ob/ob mouse. J. Clin. Invest. 96, 2065-2070 (1995).
19. Campfield, L., Smith, F., Gulsez, Y., Devos, R. & Burn, P. Mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 269, 546-549 (1995).
20. Sipols, A. J., Baskin, D. G. &. Schwartz, M. W. Effect of intracerebroventricular insulin infusion on diabetic hyperphagia and hypothalamic neuropeptide gene expression. Diabetes 44, 147-15: (1995).
21. Porte, D. J., Woods, S., Baskin, D., Seeley, R. & Schwartz, M. Obesity, diabetes and the central nervous system. Diabetologia 41, 863-881 (1998).
22. Schwartz, M. W. et al. Evidence that plasma leptin and insulin levels are associated with body adiposity via different mechanisms. Diabetes Care 20, 1476-1481 (1997).
23. Kahn, S. E. et al. Quantification of the relationship between insulin sensitivity and B-cell function in human subjects: evidence for a hyperbolic function. Diabetes 42, 1663-1672 (1993).
24. Polonsky, K. S., Given, B. D. & VanCauter, F. Twenty-four hour profiles and pulsatile patterns of insulin secretion in normal and obese subjects. J. Clin. Invest. 81, 442-448 (1988).
25. Mueller, W. et al. Evidence that glucose metabolism regulates leptin secretion from cultured rat adipocytes. Endocrinology 139, 551-558 (1998).
26. Wang, J., Liu, R., Hawkins, M., Barzilai, N. & Rossetti, L. A nutrient-sensing pathway regulates leptin gene expression in muscle and fat. Nature 393, 684-688 (1998).
27. Leedom, L. J. & Meehan, W. P. The psychoneuroendocrinology of diabetes mellitus in rodents. Psychoneuroendocrinology 14, 275-294 (1989).
28. Havel, P. et al. Marked and rapid decreases of circulating leptin in streptozotocin diabetic rats: reversal by insulin. Am. J. Physiol. 274, R1482-R1491 (1998).
29. Hathout, E. et al. Changes in plasma leptin during the treatment of diabetic ketoacidosis. J. Clin Endocrinol. Metab. 84, 4545-4548 (1999).
30. Sindelar, D. et al. Low plasma leptin levels contribute to diabetic hyperphagia in rats. Diabetes 48, 1275-1280 (1999).
31. Chua, S. C. et al. Phenotypes of mouse diabetes and rat fatty due to mutations in the OB(Leptin) receptor. Science 271, 994-996 (1996).
32. Mantzoros, C. et al. Severe leptin resistance in brown fat-deficient uncoupling protein promoter-driven diphtheria toxin A mice despite suppression of hypothalamic neuropeptide Y and circulating corticosterone. Diabetes 47, 230-238 (1998).
33. Marsh, D. J. et al. Response of melanocortin-4 receptor-deficient mice to anorectic and orexigenic peptides. Nature Genet. 21, 119-122 (1999).
34. Wilson, B. et al. Physiological and anatomical circuitry between Agouti-related protein and leptin signaling. Endocrinology 140, 2387-2397 (1999).
35. Bjorbaek, C. et al. Expression of leptin receptor isoforms in rat brain microvessels. Endocrinology 139, 3485-3491 (1998).
36. Caro, J. F. et al. Decreased cerebrospinal-fluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance. Lancet 348, 155-161 (1996).
37. Bjorbaek, C., Elmquist, J., Frantz, J., Shoelson, S. & Flier, J. Identification of SOCS-3 as a potential mediator of central leptin resistance, Mol. Cell 1, 619-635 (1998).
38. Stanley, B. G., Kyrkouli, S. E., Iampert, S. & Leibowitz, S. F. Neuropeptide Y chronically injected into the hypothalamus: a powerful neurochemical inducer of hyperphagia and obesity. Peptides 7, 1189-1192 (1986).
39. Billington, C. I., Briggs, J. E., Grace, M. & Levine, A. S. Effects of intracerebroventricular injection of neuropeptide Y on energy metabolism. Am. J. Physiol. 260, R321-R327 (1991).
40. Zarjevski, N., Cusin, I., Vetter, R., Rohner-Jeanrenaud, F. & Jeanrenaud, B. Chronic intracerebroventricular neuropeptide-Y administration to normal rats mimics hormonal and metabolic changes of obesity. Endocrinology 133, 1753-1758 (1993).
41. Kalra, S. P., Dube, M. G., Sahu, A., Phelps, C. P. & Kalra, P. Neuropeptide Y secretion increases in the paraventricular nucleus in association with increased appetite for food. Proc. Natl Acad. Sci. USA 88, 10931-10935 (1991).
42. White, J. D. & Kershaw, M. Increased hypothalamic neuropeptide Y expression following food deprivation. Mol. Cell. Neurosci. 1, 41-48 (1989).
43. Wilding, J. P. H. et al. Increased neuropeplide-Y messenger ribonucleic acid (mRNA) and decreased neurotensin mRNA in the hypothalamus of the obese (ob/ob) mouse. Endocrinology 132, 1939-1944 (1993).
44. Schwartz, M. W. et al. Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice. Diabetes 45, 531-535 (1996).
45. Stephens, T. W. et al. The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature 377, 530-534 (1995).
46. Erickson, J. C., Hollopeter, G. & Palmiter, R. D. Attenuation of the obesity syndrome of ob/ob mice by the loss of neuropeptide Y. Science 274, 1704-1707 (1996).
47. Williams, G. et al. Increased neuropeptide Y concentrations in specific hypothalamic regions of streptozocin-induced diabetic rats. Diabetes 38, 321-327 (1989).
48. Erickson, J.C., Clegg, K. E. & Palmiter, R. D. Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature 381, 415-418 (1996).
49. Cone, R. et al. The melanocortin receptors: agonists, antagonists, and the hormonal control of pigmentation. Rev. Prog. Horm. Res. 51, 287-318 (1996).
50. Bray, G. A., Fisler, J. & York, D. A. Neuroendocrine control of the development of obesity: understanding gained from studies of experimental animal models. Front. Neuroendocrinol. 11, 128-181 (1990).
51. Kow, L. & Pfaff D. The effects of the TRH -metabolite cyclo(His-Pro) and its analogs on feeding. Pharmacol. Biochem. Behav. 38, 359-364 (1991).
52. Kristensen, P. et al. Hypothalamic CART is a new anorectic peptide regulated by leptin. Nature 393, 72-76 (1998).
53. Luheshi, G., Gardner, L., Rushforth, D., Loudon, A. & Rothwell, N. Leptin actions on food intake and body temperature are mediated by II-1. Proc. Natl Acad. Sci. USA 96, 7047-7052 (1999).
54. Mountjoy, K., Mortrud, M., Low, M., Simerly, R. & Cone, R. Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain. Mol. Endocrinol. 8, 1298-1308 (1994).
55. Fan, W., Boston, B., Kesterson, R., Hruby, V. & Cone, R. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 385, 165-168 (1997).
56. Huszar, D. et al. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 88, 131-141 (1997).
57. Miller, M. et al. Cloning of the mouse agouti gene predicts a secreted protein ubiquitously expressed in mice carrying the lethal yellow mutation. Genes Dev. 7, 454-467 (1993).
58. Shutter, J. et al. Hypothalamic expression of ART, a novel gene related to agouti, is up-regulated in obese and diabetic mutant mice. Genes Dev. 11, 593-602 (1997).
59. Ollmann, M. et al. Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. Science 278, 135-138 (1997).
60. Hahn, T., Breininger, J., Baskin, D. & Schwartz, M. Coexpression of Agrp and NPY in fasting-activated hypothalamic neurons. Nature Neurosci. 1, 271-272 (1998).
61. Broberger, C., Johansen, J., Johasson, C., Schalling, M. & Hokfelt, T. The neuropeptide Y/agouti gene-related protein (AGRP) brain circuitry in normal, anorectic, and monosodium glutamate-treated mice. Proc. Natl Acad. Sci. USA 95, 15043-15048 (1998).
62. Hagan, M. et al. Effect of agouti-related peptide (83-132) on food intake: competitive melanocortin-receptor antagonism on short but not long term effects. Am. J. Physiol. (in the press).
63. Rossi, M. et al. A C-terminal fragment of Agouti-related protein increases feeding and antagonizes the effect of alpha-melanocyte stimulating hormone in vivo. Endocrinology 139, 4428-4431 (1998).
64. Stellar, E. The physiology of motivation. Psychol. Rev. 61, 5 (1954).
65. Woods, S., Seeley, R., Porte, D. J. & Schwartz, M. Signals that regulate food intake and energy homeostasis. Science 280, 1378-1383 (1998).
66. Elias, C. et al. Leptin activates hypothalamic CART neurons projecting to the spinal cord. Neuron 21, 1375-1385 (1998).
67. Satoh, N. et al. The arcuate nucleus as a primary site of satiety effect of leptin in rats. Neurosci. Lett. 224, 149-152 (1997).
68. Tang-Christensen, M., Holst, I., Hartmann, B. & Vrang, N. The arcuate nucleus is pivotal in mediating the anorectic effects of centrally administered leptin. Neuroreport, 10, 1183-1187 (1999).
69. Dawson, R., Pelleymounter, M., Millard, W., Liu, S. & Eppler, B. Attenuation of leptin-mediated effects by monosodium glutamate-induced arcuate nucleus damage. Am. J. Physiol. 273, E202-E206 (1997).
70. Schwartz, M. et al. Leptin increases hypothalamic proopiomelanocortin (POMC) mRNA expression in the rostral arcuate nucleus. Diabetes 46, 2119-2123 (1997).
71. Thornton, I., Cheung, C., Clifton, D. & Steiner, R. Regulation of hypothalamic proopiomelanocortin mRNA by leptin in ob/ob mice. Endocrinology 138, 5063-5066 (1997).
72. Hagan, M. et al. Role of the CNS melanocortin system in the response to overfeeding. J. Neurosci. 19, 2362-2367 (1999).
73. Seeley, R. et al. Melanocortin receptors in leptin effects. Nature 390, 349 (1997).
74. Elmquist, J., Maratos-Flier, E., Saper, C. & Flier, J. Unraveling the central nervous system pathways underlying responses to leptin. Nature Neurosci. 1, 445-450 (1998).
75. Elmquist, J., Elias, C. & Saper, C. From lesions to leptin: hypothalamic control of food intake and body weight. Neuron 22, 221-232 (1999).
76. Stanley, B. G., Willett, V. L. III, Donias, H. W., Ha, L. H. & Spears, L. C. The lateral hypothalamus; a primary site mediating excitatory amino acid-elicited eating. Brain Res. 630, 41-49 (1993).
77. Dallman, M. F. et al. Feast and famine: Critical role of glucocorticoids with insulin in daily energy flow. Proc. Neuroendocrinol. 14, 303-347 (1993).
78. Verbalis, J., Blackburn, R., Hoffman, G. & Stricker, E. Establishing behavioral and physiological functions of central oxytocin: insights from studies of oxytocin and ingestive behaviors. Adv. Exp. Med. Biol. 395, 209-225 (1995).
79. Qu, D. et al. A role for melanin-concentrating hormone in the central regulation of feeding behaviour. Nature 380, 243-247 (1996).
80. Shimada, M., Tritos, N., Lowell, B., Flier, I. & Maratos-Flier. E. Mice lacking melanin-concentrating hormone are hypophagic and lean. Nature 39, 670-674 (1998).
81. Saito, Y. et al. Molecular characterization of the melanin-concentrating-hormone receptor. Nature 400, 265-269 (1999).
82. Chambers, J. et al. Melanin-concent rating hormone is the cognate ligand for the orphan G-protein-coupled receptor SLC-1. Nature 400, 261-265 (1999).
83. de Lecea, L. et al. The hypocretins: hypothalamus-specific peptides with neuroexcilatory activity. Proc. Natl Acad. Sci. USA 95, 322-327 (1998).
84. Sakurai, T. et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G-protein-coupled receptors that regulate feeding behavior. Cell 92, 573-585 (1998).
85. Hagan, J. et al. Orexin A activates locus coeruleus cell firing and increases arousal in the rat. Proc. Natl Acad. Sci. USA 96, 10911-10916 (1999).
86. Chemelli, R. et al. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 98, 437-451 (1999).
87. Figlewicz, D. P., Stein, L. I., West, D., Porte, D. Jr & Woods, S. C. Intracisternal insulin alters sensitivity to CCK-induced meal suppression in baboons. Am. J. Physiol. 250, R856-R860 (1986).
88. Woods, S. C. & Strubbe, J. H. The psychobiology of meals. Psychonomic Bull. Rev. 1, 141-155 (1994).
89. Leibowitz, S. & Alexander, J. Analysis of neuropeptide Y-induced feeding: dissociation of Y1 and Y2 receptor effects on natural meal patterns. Peptides 12, 1251-1260 (1991).
90. Flynn, M., Scott, T., Pritchard, T. & Plata-Salaman, C. Mode of action of OB protein (leptin) on feeding. Am. J. Physiol. 275, R174-R179 (1998).
91. Ritter, S., Dinh, T. & Friedman, M. Induction of Fos-like immunoreactivity (Fos-li) and stimulation of feeding by 2,5-anhydro-D-mannitol (2,5-AM) require the vagus nerve. Brain Res. 646, 53-64 (1994).
92. Travers, S. & Norgren, R. Gustatory neural processing in the hindbrain. Annu. Rev. Neurosci. 10, 595-632 (1987).
93. Friedman, M., Harris, R., Ji, H., Ramirez, I. & Tordoff, M. Fatty acid oxidation affects food intake by altering hepatic energy status. Am. J. Physiol 276, R1046-R1053 (1999).
94. Moran, T. & Schwartz, G. Neurobiology of cholecystokinin. Crit. Rev. Neurobiol. 9, 1-28 (1994).
95. Grill, H. & Smith, G. Cholecystokinin decreases sucrose intake in chronic decerebrate rats. Am. J. Physiol. 254, R853-R856 (1988).
96. Matson, C. & Ritter, R. Long-term CCK-leptin synergy suggests a role for CCK in the regulation of body weight. Am. J. Physiol. 276, R1038-R1045 (1999).
97. Emond, M., Schwartz, G., Ladenheim, E. & Moran, T. Central leptin modulates behavioral and neural responsivity to CCK. Am. J. Physiol. 276, R1545-R1549 (1999).
98. Ter Hurst, G., de Boer, P., Luiten, P. & van Willigen, J. Ascending projections from the solitary tract nucleus to the hypothalamus. A Phaseolus vulgaris lectin tracing study in the rat. Neuroscience 31, 785-797 (1989).
99. Grill, H., Ginsberg, A., Seeley, R. & Kaplan, J. Brainstem application of melanocortin receptor ligands produces long-lasting effects on feeding and body weight. J. Neurosci. 18, 10128-10135 (1998).
100. Mercer, J., Moar, K. & Hoggard, N. Localization of leptin receptor (Ob-R) messenger ribonucleic acid in the rodent hindbrain. Endocrinology 139, 29-34 (1998).
101. Bronstein, D., Schafer, M., Watson, S. & Akil, H. Evidence that beta-endorphin is synthesized in cells in the nucleus tractus solitarius: detection of POMC mRNA. Brain Res. 587, 269-275 (1992).
102. Leibowitz, S., Roossin, P. & Rosenn, M. Chronic norepinephrine injection into the hypothalamic paraventricular nucleus produces hyperphagia and increased body weight in the rat. Pharmacol. Biochem. Behav. 21, 801-808 (1984).
103. Oltmans, G. Norepinephrine and dopamine levels in hypothalamic nuclei of the genetically obese mouse (ob/ob). Brain Res. 273, 369-373 (1983).
104. Brunetti, L., Michelotto, B., Orlando, G. & Vacca, M. Leptin inhibits norepinephrine and dopamine release from rat hypothalamic neuronal endings. Eur. J. Pharmacol. 372, 237-240 (1999).
105. Salamone, J., Mahan, K. & Rogers, S. Ventrolateral striatal dopamine depletions impair feeding and food handling in rats. Pharmacol. Biochem. Behav. 44, 605-610 (1993).
106. Szczypka, M. et al. Feeding behavior in dopamine-deficient mice. Proc. Natl Acad. Sci. USA 96, 12138-12143 (1999).
107. Pothos, E., Creese, I. & Hoebel, B. Restricted eating with weight loss selectively decreases extracellular dopamine in the nucleus accumbens and alters dopamine response to amphetamine, morphine, and food intake. J. Neurosci. 15, 6640-6650 (1995).
108. Figlewicz, D., Endocrine regulation of neurotransmitter transporters. Epilepsy Res. 37, 203-210 (1999).
109. Patterson, T. et al. Food deprivation decreases mRNA and activity of the rat dopamine transporter. Neuroendocrinology 68, 11-20 (1998).
110. Leibowitz, S. & Alexander, J. Hypothalamic serotonin in control of eating behavior, meal size, and body weight. Biol. Psychiatry 44, 851-864 (1998).
111. Nonogaki, K., Strack, A., Dallman, M. & Tecott, L. Leptin-independent hyperphagia and type 2 diabetes in mice with a mutated serotonin 5-HT receptor gene. Nature Med. 4, 1152-1156 (1998).
112. Calapai, G. et al. Leptin increases serotonin turnover by inhibition of brain nitric oxide synthesis. J. Clin. Invest. 104, 475-982 (1999).
113. Yaswen, L., Dichl, N., Brennam, M. & Hochgeschwender, V. Obesity in the mouse model of proopiomelanocortin deficiency responds to peripheral melanocortin. Nature Med. 5, 1066-1070 (1999).
114. Farooqi, I. et al. Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N. Engl. J. Med. 341, 879-884 (1999).
115. Cheatham, B. & Kahn, C. Insulin action and the insulin signaling network. Endocr. Rev. 16, 117-142 (1995).
116. Baskin, D. G., Sipols, A. J., Schwartz, M. W. & White, M. F. Insulin receptor substrate-1 (IRS-1) expression in rat brain. Endocrinology 134, 1932-1955 (1994).
117. Kapeller, R. et al. Tyrosine phosphorylation of tub and its association with Src homology 2 domain-containing proteins implicate tub in intracellular signaling by insulin. J. Biol. Chem. 274, 24980-24986 (1999).
118. Tartaglia, L. A. et al. Identification and expression cloning of a leptin receptor, OB-R. Cell 83, 1263-1271 (1995).
119. Tartaglia, L. A. The leptin receptor. J. Biol. Chem. 272, 6093-6096 (1997).
120. Spanswick, D., Smith, M., Groppi, V., Logam, S. & Ashford, M. Leptin inhibits hypothalamic neurons by activation of ATP-sensitive potassium channels. Nature 390, 521-525 (1997).
121. + channel in rat brain. Brain Res. 814, 41-54 (1998).